These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 26493269

  • 1. Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts.
    Vigneswaran S, Rojas JH, Garvey L, Taylor-Robinson S, Winston A.
    Neuroradiol J; 2015 Dec; 28(6):545-54. PubMed ID: 26493269
    [Abstract] [Full Text] [Related]

  • 2. A comparison of two post-processing analysis methods to quantify cerebral metabolites measured via proton magnetic resonance spectroscopy in HIV disease.
    Scott J, Underwood J, Garvey LJ, Mora-Peris B, Winston A.
    Br J Radiol; 2016 Dec; 89(1060):20150979. PubMed ID: 26954329
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.
    Bladowska J, Zimny A, Kołtowska A, Szewczyk P, Knysz B, Gąsiorowski J, Furdal M, Sąsiadek MJ.
    Eur J Radiol; 2013 Apr; 82(4):686-92. PubMed ID: 23246331
    [Abstract] [Full Text] [Related]

  • 4. Alterations in cerebrospinal fluid chemokines are associated with maraviroc exposure and in vivo metabolites measurable by magnetic resonance spectroscopy.
    Vera JH, Garvey LJ, Allsop JM, Kaye S, McClure MO, Back D, Taylor-Robinson SD, Winston A.
    HIV Clin Trials; 2012 Apr; 13(4):222-7. PubMed ID: 22849963
    [Abstract] [Full Text] [Related]

  • 5. Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy.
    Winston A, Duncombe C, Li PC, Gill JM, Kerr SJ, Puls RL, Taylor-Robinson SD, Emery S, Cooper DA, Altair Study Group.
    Neuroradiology; 2012 Dec; 54(12):1331-9. PubMed ID: 22772471
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Does acute hepatitis C infection affect the central nervous system in HIV-1 infected individuals?
    Winston A, Garvey L, Scotney E, Yerrakalva D, Allsop JM, Thomson EC, Grover VP, Main J, Cox JI, Wylezinska M, Taylor-Robinson SD.
    J Viral Hepat; 2010 Jun; 17(6):419-26. PubMed ID: 19780944
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J, Zimny A, Knysz B, Małyszczak K, Kołtowska A, Szewczyk P, Gąsiorowski J, Furdal M, Sąsiadek MJ.
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [Abstract] [Full Text] [Related]

  • 9. Two-dimensional 1H MR spectroscopy of the brain in human immunodeficiency virus (HIV)-infected children.
    Banakar S, Thomas MA, Deveikis A, Watzl JQ, Hayes J, Keller MA.
    J Magn Reson Imaging; 2008 Apr; 27(4):710-7. PubMed ID: 18383256
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
    Chang L, Lee PL, Yiannoutsos CT, Ernst T, Marra CM, Richards T, Kolson D, Schifitto G, Jarvik JG, Miller EN, Lenkinski R, Gonzalez G, Navia BA, HIV MRS Consortium.
    Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
    [Abstract] [Full Text] [Related]

  • 13. Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition.
    Byrnes V, Miller A, Lowry D, Hill E, Weinstein C, Alsop D, Lenkinski R, Afdhal NH.
    J Hepatol; 2012 Mar; 56(3):549-56. PubMed ID: 22027578
    [Abstract] [Full Text] [Related]

  • 14. Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy.
    Bokemeyer M, Ding XQ, Goldbecker A, Raab P, Heeren M, Arvanitis D, Tillmann HL, Lanfermann H, Weissenborn K.
    Gut; 2011 Mar; 60(3):370-7. PubMed ID: 20926642
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intralipid/Heparin Infusion Alters Brain Metabolites Assessed With 1H-MRS Spectroscopy in Young Healthy Men.
    Karczewska-Kupczewska M, Nikolajuk A, Filarski R, Majewski R, Tarasów E.
    J Clin Endocrinol Metab; 2018 Jul 01; 103(7):2563-2570. PubMed ID: 29860500
    [Abstract] [Full Text] [Related]

  • 19. Biochemical abnormalities in basal ganglia and executive dysfunction in acute- and euthymic-episode patients with bipolar disorder: A proton magnetic resonance spectroscopy study.
    Lai S, Zhong S, Liao X, Wang Y, Huang J, Zhang S, Sun Y, Zhao H, Jia Y.
    J Affect Disord; 2018 Jan 01; 225():108-116. PubMed ID: 28818755
    [Abstract] [Full Text] [Related]

  • 20. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T, Xiao S, Li X, Ding B, Ling H, Chen K, Fang Y.
    Int Psychogeriatr; 2012 Jan 01; 24(1):19-27. PubMed ID: 21676281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.